touchINFECTIOUSDISEASES were pleased to meet with Lulu (Gonasagrie) Nair (Stellenbosch University, Stellenbosch, South Africa) to discuss the interim results from the REACH study.
The abstract entitled: ‘Adherence to the dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study’ was presented at IAS 2021 – the 11th International AIDS Society Conference on HIV Science (Virtual).
- What were the aims, design and eligibility of the REACH study? (0:21)
- What were the findings in terms of adherence? (0:53)
- What were the attitudes of the users towards these products? (2:04)
- What have we learned in terms of future clinical practice and what future studies are planned? (2:34)
Disclosures: Lulu (Gonasagrie) Nair has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed in coverage of IAS 2021 Virtual.
Share this Video
Related Videos In HIV
18th European AIDS Conference 2021: Welcome from Sanjay Bhagani
Dr Sanjay Bhagani invites you to join the 18th European AIDS Conference (EACS 2021). The conference will be organised in a hybrid format from October 27-30, 2021. The onsite Conference in London will take place, following a comprehensive COVID-19 health and safety concept, complemented by an engaging and interactive online platform that mirrors the scientific […]
Kelly Dooley, ECCMID 2021: Challenges in Developing New Treatments for Drug-resistant Tuberculosis
It was a pleasure to meet with Kelly Dooley (Johns Hopkins University School of Medicine, Baltimore, MD, USA) to discuss the major challenges to developing new treatment regimens for drug-resistant tuberculosis. The session entitled: ‘New drugs and new regimens for treating drug-resistant tuberculosis’ was presented at the 31st European Congress of Clinical Microbiology & Infectious […]
David Lawrence, IAS 2021: Phase 3 AMBITION Trial Results
We had the pleasure to meet with David Lawrence (London School of Hygiene and Tropical Medicine, London, UK) to discuss the phase 3 AMBITION trial results investigating liposomal amphotericin for treatment of HIV-associated Cryptococcal Meningitis. The abstract entitled: ‘Single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis: results of the phase-3 Ambition-cm […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!